- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the pharmacodynamic profile of a 6-month sustained-release formulation of triptorelin administered as two simultaneous subcutaneous microimplant injections (2x6 mg) by measuring serum testosterone levels.
Inclusion criteria
- Locally advanced or metastatic prostate cancer